EGFR has been extensively studied as a driver of gliomas in the past (reviewed in Saadeh et al., 2018), and the association of this gene and transcript with outcome has been a matter of debate (Li et al., 2018; Saadeh et al., 2018; Xu et al., 2017). Here, EGFR is linked to central nervous system cancer.